LA JOLLA INFECTIOUS DISEASE INSTITUTE
Data sourced from IRS 990 public filings
La Jolla Infectious Disease Institute THE ADVANCEMENT OF SCIENCE AND FOR RESEARCH PURPOSES AS DEFINED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, INCLUDING TREATMENT, RESEARCH DESIGN AND METHODS AND KNOWLEDGE RELATED TO THE ALLERGIC RESPONSE, INFECTIOUS DISEASE AND IMMUNOLOGIC PATHWAYS.
LA JOLLA INFECTIOUS DISEASE INSTITUTE has received 2 grants from 2 known foundation funders. Revenue decreased from $516,793 in 2022 to $10,718 in 2024. Most recent reported revenue: $10,718.
Annual Revenue
$10,718
Known Funders
2
Grants Received
2
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $10,718 | $16 | $0 |
| 2022 | $516,793 | $440,978 | $26,042 |
| 2021 | $219,974 | $432,211 | $7,862 |
| 2020 | $307,799 | $477,000 | $24,259 |
| 2019 | $278,057 | $399,266 | $39,912 |
| 2018 | $290,954 | $355,011 | $11,633 |
| 2017 | $278,939 | $337,142 | $72,704 |
| 2016 | $377,285 | $448,711 | $3,946 |
Top Funders
BALTIMORE, MD
Key Personnel
From 2024 IRS 990 filing
AUTEL PATEL
DIRECTOR
KENNY CHU
DIRECTOR
GEORGES E GRAU MD PHD
DIRECTOR
HENRI VAN DER HEYDE PHD
CFO
WUN-LING CHANG MD
PRESIDENT, CEO
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.